Abstract
Despite many significant advances in cancer treatment and care, cancer remains the second leading cause of death in the United States.1 Nevertheless, improvements in cancer treatment and care have led to a 50% increase in cancer survivorship, compared to 30 years ago.1 Currently 62% of cancer survivors can now expect to live at least 5 years past their original diagnosis and there are almost 10 million cancer survivors in the United States.1 As a result of this increase in survivorship the issues and problems facing cancer survivors, whether psychosocial or physical, assume increasingly greater significance, most importantly to the individual survivor, and also to the broader issue of public health.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
ACS. Cancer Facts & Figures 2005. American Cancer Society: Atlanta, 2005.
Curt, G.A., Breitbart, W., Cella, D., et al. Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. Oncologist 2000; 5(5): 353–60.
Vogelzang, N.J., Breitbart, W., Cella, D., et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey. The Fatigue Coalition. Semin. Hematol. 1997; 34(3, Suppl 2): 4–12.
Blesch, K.S., Paice, J.A., Wickham, R., et al. Correlates of fatigue in people with breast or lung cancer. Oncol. Nurs. Forum 1991; 18(1): 81–7.
Lawrence, D.P., Kupelnick, B., Miller, K., Devine, D., and Lau, J. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients [Monographs]. J. Natl. Cancer Inst. 2004; (32): 40–50.
Hjermstad, M.J., Oldervoll, L., Fossa, S.D., Holte, H., Jacobsen, A.B., and Loge, J.H. Quality of life in long-term Hodgkin's disease survivors with chronic fatigue. Eur. J. Cancer 2006; 42(3): 327–33.
Nail, L.M., and Jones, L.S. Fatigue as a side effect of cancer treatment: Impact on quality of life. Qual. Life 1995; 4(1): 8–13.
Berglund, G., Bolund, C., Fornander, T., Rutqvist, L.E., and Sjoden, P.O. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur. J. Cancer 1991; 27(9): 1075–81.
Hjermstad, M.J., Fossa, S.D., Oldervoll, L., Holte, H., Jacobsen, A.B., and Loge, J.H. Fatigue in long-term Hodgkin's Disease survivors: A follow-up study. J. Clin. Oncol. 2005; 23(27): 6587–95.
Bower, J.E., Ganz, P.A., Desmond, K.A., Rowland, J.H., Meyerowitz, B.E., and Belin, T.R. Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. J. Clin. Oncol. 2000; 18(4): 743–53.
Broeckel, J.A., Jacobsen, P.B., Horton, J., Balducci, L., and Lyman, G.H. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J. Clin. Oncol. 1998; 16(5): 1689–96.
Fossa, S.D., Dahl, A.A., and Loge, J.H. Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J. Clin. Oncol. 2003; 21(7): 1249–54.
King, K.B., Nail, L.M., Kreamer, K., Strohl, R.A., and Johnson, J.E. Patients' descriptions of the experience of receiving radiation therapy. Oncol. Nurs. Forum 1985; 12(4): 55–61.
Loge, J.H., Abrahamsen, A.F., Ekeberg, O., and Kaasa, S. Hodgkin's disease survivors more fatigued than the general population. J. Clin. Oncol. 1999; 17(1): 253–61.
NCCN. Cancer-Related Fatigue and Anemia: Treament Guidelines for Patients, Version II. http:/kern-3ptwww.nccn.org. Accessed January 18, 2006.
Glaus, A., Crow, R., and Hammond, S. A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Eur. J. Cancer Care 1996; 5(2 Suppl): 8–23.
Andrykowski, M.A., Curran, S.L., and Lightner, R. Off-treatment fatigue in breast cancer survivors: A controlled comparison. J. Behav. Med. 1998; 21(1): 1–18.
Jacobsen, P.B., Hann, D.M., Azzarello, L.M., Horton, J., Balducci, L., and Lyman, G.H. Fatigue in women receiving adjuvant chemotherapy for breast cancer: Characteristics, course, and correlates. J. Pain Symptom Manage. 1999; 18(4): 233–42.
Piper, B.F. Fatigue and cancer: Inevitable companions?[comment]. Support. Care Cancer 1993; 1(6): 285–6.
Winningham, M.L., Nail, L.M., Burke, M.B., et al. Fatigue and the cancer experience: The state of the knowledge. Oncol. Nurs. Forum 1994; 21(1): 23–36.
Jacobsen, P.B. Assessment of fatigue in cancer patients [Monographs]. J. Natl. Cancer Inst. 2004; (32): 93–7.
Mock, V. Evidence-based treatment for cancer-related fatigue [Monographs]. J. Natl. Cancer Inst. 2004; (32): 112–18.
Piper, B.F., Dibble, S.L., Dodd, M.J., Weiss, M.C., Slaughter, R.E., and Paul, S.M. The revised Piper Fatigue Scale: Psychometric evaluation in women with breast cancer. Oncol. Nurs. Forum 1998; 25(4): 677–84.
Greenberg, D.B., Gray, J.L., Mannix, C.M., Eisenthal, S., and Carey, M. Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. J. Pain Symptom Manage. 1993; 8(4): 196–200.
Greenberg, D.B., Sawicka, J., Eisenthal, S., and Ross, D. Fatigue syndrome due to localized radiation. J. Pain Symptom Manage. 1992; 7(1): 38–45.
Haylock, P.J., and Hart, L.K. Fatigue in patients receiving localized radiation. Cancer Nurs. 1979; 2(6): 461–7.
Hickok, J.T., Morrow, G.R., McDonald, S., and Bellg, A.J. Frequency and correlates of fatigue in lung cancer patients receiving radiation therapy: Implications for management. J. Pain Symptom Manage. 1996; 11(6): 370–7.
Irvine, D., Vincent, L., Graydon, J.E., Bubela, N., and Thompson, L. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs. 1994; 17(5): 367–78.
Irvine, D.M., Vincent, L., Bubela, N., Thompson, L., and Graydon, J. A critical appraisal of the research literature investigating fatigue in the individual with cancer. Cancer Nurs. 1991; 14(4): 188–99.
Given, C.W., Given, B., Azzouz, F., Kozachik, S., and Stommel, M. Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. J. Pain Symptom Manage. 2001; 21(6): 456–66.
Smets, E.M., Visser, M.R., Willems-Groot, A.F., Garssen, B., Schuster-Uitterhoeve, A.L., and de Haes, J.C. Fatigue and radiotherapy: (B) Experience in patients 9 months following treatment. Br. J. Cancer 1998; 78(7): 907–12.
Morrow, G.R., Shelke, A.R., Roscoe, J.A, Hickok, J.T, and Mustian, K. Management of cancer-related fatigue. Cancer Invest. 2005; 23(3): 229–39.
Ancoli-Israel, S., Moore, P.J., and Jones, V. The relationship between fatigue and sleep in cancer patients: A review. Eur. J. Cancer Care 2001; 10(4): 245–55.
Theobald, D.E. Cancer pain, fatigue, distress, and insomnia in cancer patients. Clin. Cornerstone. 2004; 6 (Suppl 1D): S15–21.
Valentine, A.D., and Meyers, C.A. Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer 2001; 92(6 Suppl): 1694–8.
Glaspy, J. Anemia and fatigue in cancer patients. Cancer 2001; 92(6 Suppl): 1719–24.
Gutstein, H.B. The biologic basis of fatigue. Cancer 2001; 92(6 Suppl): 1678–83.
Kurzrock, R. The role of cytokines in cancer-related fatigue. Cancer 2001; 92(6 Suppl): 1684–8.
Morrow, G.R., Andrews, P.L., Hickok, J.T., Roscoe, J.A., and Matteson, S. Fatigue associated with cancer and its treatment. Support. Care in Cancer 2002; 10(5): 389–98.
Tisdale, M.J. Wasting in cancer. J. Nutr. 1999; 129(1S Suppl): 243S–6S.
Bruera, E., Brenneis, C., Michaud, M., Jackson, P.I., and MacDonald, R.N. Muscle electrophysiology in patients with advanced breast cancer. J. Natl. Cancer Inst. 1988; 80(4): 282–5.
Ng, A.V., Alt, C., Gore, E., et al. Mechanisms of fatigue in cancer survivors. Med. Sci. Sports Exerc.: Abstract Issue. 2006; S38.
Ranganathan, V., Siemionow, V., Davis, M., et al. Cancer-related fatigue is associated with neuropsychological and neuromuscular junction impairments. 2005: Program No. 398.399. 2005 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, Online.
Malik, U.R., Makower, D.F., and Wadler, S. Interferon-mediated fatigue. Cancer 2001; 92(6 Suppl): 1664–8.
Wu, H.S., and McSweeney, M. Measurement of fatigue in people with cancer. Oncol. Nurs. Forum 2001; 28(9): 1371–84; quiz 1385–1376.
Portenoy, R.K., and Itri, L.M. Cancer-related fatigue: Guidelines for evaluation and management.[see comment][comment]. Oncologist 1999; 4(1): 1–10.
Mock, V. Fatigue management: Evidence and guidelines for practice. Cancer 2001; 92(6 Suppl): 1699–1707.
Smets, E.M., Garssen, B., Schuster-Uitterhoeve, A.L., and de Haes, J.C. Fatigue in cancer patients. Br. J. Cancer 1993; 68(2): 220–4.
Ahlberg, K., Ekman, T., Gaston-Johansson, F., and Mock, V. Assessment and management of cancer-related fatigue in adults. Lancet 2003; 362(9384): 640–50.
Piper, B., Lindsey, A.M., Dodd, M., Ferketich, S., Paul, S.M., and Weller, S. The development of an instrument to measure the subjective dimension of fatigue. In: Funk, S., Tournquist, E., Champagne, M., Copp, L., Weise, R. (eds.). Key Aspects of Comfort; Management of pain, fatigue, and nausea. Springer: New York, 1989, pp. 199–208.
Hann, D.M., Denniston, M.M., and Baker, F. Measurement of fatigue in cancer patients: Further validation of the Fatigue Symptom Inventory. Qual. Life Res. 2000; 9(7): 847–54.
Sood, A., and Moynihan, T.J. Cancer-related fatigue: An update. Curr. Oncol. Rep. 2005; 7(4): 277–82.
Pirl, W.F., and Roth, A.J. Diagnosis and treatment of depression in cancer patients. Oncology (Huntington) 1999 Sep 1305; 13(9): 1293–1301.
DeFlorio, M., and Massie, M.J. Review of depression in cancer: Gender differences. Depression 1995; 3: 66–80.
Derogatis, L.R., Morrow, G.R., Fetting, J., et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983; 249(6): 751–57.
McDaniel, J.S., Musselman, D.L., Porter, M.R., Reed, D.A., and Nemeroff, C.B. Depression in patients with cancer. Diagnosis, biology, and treatment. Arch. Gen. Psychiatry 1995; 52(2): 89–99.
Henriksson, M.M., Isometsa, E.T., Hietanen, P.S., Aro, H.M., and Lonnqvist, J.K. Mental disorders in cancer suicides. J. Affect. Disord. 1995; 36(1–2): 11–20.
Reuter, K., and Harter, M. The concepts of fatigue and depression in cancer. Eur. J. Cancer Care 2004; 13(2): 127–34.
Jacobsen, P.B., Donovan, K.A., and Weitzner, M.A. Distinguishing fatigue and depression in patients with cancer. Semin. Clin. Neuropsychiatry 2003; 8(4): 229–40.
Tchekmedyian, N.S., Kallich, J., McDermott, A., Fayers, P., and Erder, M.H. The relationship between psychologic distress and cancer-related fatigue. Cancer 2003; 98(1): 198–203.
Ahlberg, K., Ekman, T., Wallgren, A., and Gaston-Johansson, F. Fatigue, psychological distress, coping and quality of life in patients with uterine cancer. J. Adv. Nurs. 2004; 45(2): 205–13.
Chang, C.H., Nyenhuis, D.L., Cella, D., Luchetta, T., Dineen, K., and Reder, A.T. Psychometric evaluation of the Chicago Multiscale Depression Inventory in multiple sclerosis patients. Mult. Scler. 2003; 9(2): 160–70.
Morrow, G.R., Hickok, J.T., Roscoe, J.A., et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J. Clin. Oncol. 2003; 21(24): 4635–41.
Checkley, S. The neuroendocrinology of depression and chronic stress. Br. Med. Bull. 1996; 52(3): 597–617.
Dunlop, R.J., and Campbell, C.W. Cytokines and advanced cancer. J. Pain Symptom Manage. 2000; 20(3): 214–32.
Licinio, J., and Wong, M.L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry 1999; 4(4): 317–27.
Maier, S.F., and Watkins, L.R. Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol. Rev. 1998; 105(1): 83–107.
Mastorakos, G., Chrousos, G.P., and Weber, J.S. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J. Clin. Endocrinol. Metab. 1993; 77(6): 1690–94.
Turnbull, A.V., and Rivier, C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action. Physiol. Rev. 1999; 79(1): 1–71.
Geffken, G.R., Ward, H.E., Staab, J.P., Carmichael, S.L., and Evans, D.L. Psychiatric morbidity in endocrine disorders. Psychiatr. Clin. North Am. 1998; 21(2): 473–89.
Michelson, D., and Gold, P.W. Pathophysiologic and somatic investigations of hypothalamic-pituitary-adrenal axis activation in patients with depression. Ann. N. Y. Acad. Sci. 1998; 840: 717–22.
Gottschalk, M., Kumpfel, T., Flachenecker, P., et al. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch. Neurol. 2005; 62(2): 277–80.
Scott, L.V., and Dinan, T.G. The neuroendocrinology of chronic fatigue syndrome: Focus on the hypothalamic-pituitary-adrenal axis. Funct. Neurol. 1999; 14(1): 3–11.
Elenkov, I.J., Wilder, R.L., Chrousos, G.P., and Vizi, E.S. The sympathetic nerve–an integrative interface between two supersystems: The brain and the immune system. Pharmacol. Rev. 2000; 52(4): 595–638.
Vgontzas, A.N., and Chrousos, G.P. Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: Multiple interactions and disturbances in sleep disorders. Endocrinol. Metab. Clin. North Am. 2002; 31(1): 15–36.
O'Donnell, J.F. Insomnia in cancer patients. Clin. Cornerstone 2004; 6 (Suppl 1D): S6–14.
Bower, J.E., Ganz, P.A., Dickerson, S.S., Petersen, L., Aziz, N., and Fahey, J.L. Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 2005; 30(1): 92–100.
Spencer, S.M., Lehman, J.M., Wynings, C., et al. Concerns about breast cancer and relations to psychosocial well-being in a multiethnic sample of early-stage patients. Health Psychol. 1999; 18(2): 159–68.
Vickberg, S.M. The Concerns About Recurrence Scale (CARS): A systematic measure of women's fears about the possibility of breast cancer recurrence. Ann. Behav. Med. 2003; 25(1): 16–24.
Vickberg, S.M., Bovbjerg, D.H., DuHamel, K.N., Currie, V., and Redd, W.H. Intrusive thoughts and psychological distress among breast cancer survivors: Global meaning as a possible protective factor. Behav. Med. 2000; 25(4): 152–60.
al-Majid, S., and McCarthy, D.O. Cancer-induced fatigue and skeletal muscle wasting: The role of exercise. Biol. Res. Nurs. 2001; 2(3): 186–97.
Baracos, V.E. Management of muscle wasting in cancer-associated cachexia: Understanding gained from experimental studies. Cancer 2001; 92(6 Suppl): 1669–77.
St Pierre, B.A., Kasper, C.E., and Lindsey, A.M. Fatigue mechanisms in patients with cancer: Effects of tumor necrosis factor and exercise on skeletal muscle. Oncol. Nurs. Forum 1992; 19(3): 419–25.
Ovesen, L., Allingstrup, L., Hannibal, J., Mortensen, E.L., and Hansen, O.P. Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: A prospective, randomized study. J. Clin. Oncol. 1993; 11(10): 2043–9.
Klein, S., Kinney, J., Jeejeebhoy, K., et al. Nutrition support in clinical practice: Review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am. J. Clin. Nutr. 1997; 66(3): 683–706.
Evans, W.K., Makuch, R., Clamon, G.H., et al. Limited impact of total parenteral nutrition on nutritional status during treatment for small cell lung cancer. Cancer Res. 1985; 45(7): 3347–53.
Costa, G. Cachexia, the metabolic component of neoplastic diseases. Cancer Res. 1977; 37(7 Pt 2): 2327–35.
Tisdale, M.J. Biology of cachexia.[see comment]. J. Natl. Cancer Inst. 1997; 89(23): 1763–73.
Argiles, J.M., and Lopez-Soriano, F.J. The role of cytokines in cancer cachexia. Med. Res. Rev. 1999; 19(3): 223–48.
Mock, V., and Olsen, M. Current management of fatigue and anemia in patients with cancer. Semin. Oncol. Nurs. 2003; 19(4 Suppl 2): 36–41.
Cella, D., Zagari, M.J., Vandoros, C., Gagnon, D.D., Hurtz, H.J., and Nortier, J.W. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. J. Clin. Oncol. 2003; 21(2): 366–73.
Crawford, J., Cella, D., Cleeland, C.S., et al. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.[see comment]. Cancer 2002; 95(4): 888–95.
Cella, D., Lai, J.S., Chang, C.H., Peterman, A., and Slavin, M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 2002; 94(2): 528–38.
Kanzaki, M., Soda, K., Gin, P.T., Kai, T., Konishi, F., and Kawakami, M. Erythropoietin attenuates cachectic events and decreases production of interleukin-6, a cachexia-inducing cytokine. Cytokine 2005; 32(5): 234–9.
Courneya, K.S. Exercise in cancer survivors: an overview of research. Med. Sci. Sports Exerc. 2003; 35(11): 1846–52.
Watson, T., and Mock, V. Exercise as an intervention for cancer-related fatigue. Phys. Ther. 2004; 84(8): 736–43.
Windsor, P.M., Nicol, K.F., and Potter, J. A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 2004; 101(3): 550–7.
Bartholomew, J.B., Morrison, D., and Ciccolo, J.T. Effects of acute exercise on mood and well-being in patients with major depressive disorder. Med. Sci. Sports Exerc. 2005; 37(12): 2032–7.
Byrne, A., andByrne, D.G. The effect of exercise on depression, anxiety and other mood states: A review. J. Psychosom. Res. 1993; 37(6): 565–74.
Dimeo, F.C., Stieglitz, R.D., Novelli-Fischer, U., Fetscher, S., and Keul, J. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 1999; 85(10): 2273–7.
Fairey, A.S., Courneya, K.S., Field, C.J., Bell, G.J., Jones, L.W., and Mackey, J.R. Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J. Appl. Physiol. 2005; 98(4): 1534–40.
Hutnick, N.A., Williams, N.I., Kraemer, W.J., et al. Exercise and lymphocyte activation following chemotherapy for breast cancer. Med. Sci. Sports Exerc. 2005; 37(11): 1827–35.
Fairey, A.S., Courneya, K.S., Field, C.J., and Mackey, J.R. Physical exercise and immune system function in cancer survivors: A comprehensive review and future directions. Cancer 2002; 94(2): 539–51.
Zinna, E.M., and Yarasheski, K.E. Exercise treatment to counteract protein wasting of chronic diseases. Curr. Opin. Clin. Nutr. Metab. Care 2003; 6(1): 87–93.
Monga, U., Jaweed, M., Kerrigan, A.J., et al. Neuromuscular fatigue in prostate cancer patients undergoing radiation therapy. Arch. Phys. Med. Rehabil. 1997; 78(9): 961–6.
Sharma, K.R., Kent-Braun, J., Mynhier, M.A., Weiner, M.W., and Miller, R.G. Evidence of an abnormal intramuscular component of fatigue in multiple sclerosis. Muscle Nerve 1995; 18(12): 1403–11.
Sheean, G.L., Murray, N.M., Rothwell, J.C., Miller, D.H., and Thompson, A.J. An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain 1997; 120(Pt 2): 299–315.
Bigland-Ritchie, B., and Woods, J.J. Changes in muscle contractile properties and neural control during human muscular fatigue. Muscle Nerve 1984; 7(9): 691–9.
Edwards, R.H.T. Human muscle function and fatigue. In: Porter, R., and Whelan, J. (eds.). Human Muscle Fatigue: Physiological Mechanisms. Pitman Medical: London, 1981, pp. 1–18.
Kent-Braun, J.A. Noninvasive measures of central and peripheral activation in human muscle fatigue. Muscle Nerve Suppl. 1997; 5: S98–101.
Merton, P.A. Voluntary strength and fatigue. J. Physiol. 1954; 123(3): 553–64.
Bigland-Ritchie, B., Furbush, F., and Woods, J.J. Fatigue of intermittent submaximal voluntary contractions: Central and peripheral factors. J. Appl. Physiol. 1986; 61(2): 421–9.
Ng, A.V., Miller, R.G., and Kent-Braun, J.A. Central motor drive is increased during voluntary muscle contractions in multiple sclerosis. Muscle Nerve 1997; 20(10): 1213–18.
Gillette, E.L., Mahler, P.A., Powers, B.E., Gillette, S.M., and Vujaskovic, Z. Late radiation injury to muscle and peripheral nerves. Int. J. Radiat. Oncol. Biol. Phys. 1995; 31(5): 1309–18.
Sharabi, Y., Dendi, R., Holmes, C., and Goldstein, D.S. Baroreflex failure as a late sequela of neck irradiation. Hypertens. 2003; 42(1): 110–16.
Shaw, E.G., Gunderson, L.L., Martin, J.K., Beart, R.W., Nagorney, D.M., and Podratz, K.C. Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: Clinical and dose-response analysis. Radiother. Oncol. 1990; 18(3): 247–55.
Kent-Braun, J.A., Miller, R.G., and Weiner, M.W. Human skeletal muscle metabolism in health and disease: Utility of magnetic resonance spectroscopy. In: Holloszy, J.O. (ed.). Exercise and Sports Sciences Reviews, Vol. 23. Williams & Wilkins: Baltimore, 1995.
Ng, A.V., Dao, H.T., Miller, R.G., Gelinas, D.F., and Kent-Braun, J.A. Blunted pressor and intramuscular metabolic responses to voluntary isometric exercise in multiple sclerosis.[see comment]. J. Appl. Physiol. 2000; 88(3): 871–80.
Kinsella, T.J., Sindelar, W.F., DeLuca, A.M., et al. Tolerance of peripheral nerve to intraoperative radiotherapy (IORT): Clinical and experimental studies. Int. J. Radiat. Oncol. Biol. Phys. 1985; 11(9): 1579–85.
Wardell, T.M., Ferguson, E., Chinnery, P.F., et al. Changes in the human mitochondrial genome after treatment of malignant disease. Mutat. Res. 2003; 525(1–2): 19–27.
Taivassalo, T., and Haller, R.G. Exercise and training in mitochondrial myopathies. Med. Sci. Sports Exerc. 2005; 37(12): 2094–101.
Berger, A.M. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol. Nurs. Forum 1998; 25(1): 51–62.
Sarna, L., and Conde F. Physical activity and fatigue during radiation therapy: A pilot study using actigraph monitors. Oncol. Nurs. Forum 2001; 28(6): 1043–6.
Bou-Holaigah, I., Rowe, P.C., Kan, J., and Calkins, H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome.[see comment]. JAMA 1995; 274(12): 961–7.
Freeman, R., and Komaroff, A.L. Does the chronic fatigue syndrome involve the autonomic nervous system? Am. J. Med. 1997; 102(4): 357–64.
Timmers, H.J., Karemaker, J.M., Lenders, J.W., and Wieling, W. Baroreflex failure following radiation therapy for nasopharyngeal carcinoma. Clin. Auton. Res. 1999; 9(6): 317–24.
Bruera, E., Chadwick, S., Fox, R., Hanson, J., and MacDonald, N. Study of cardiovascular autonomic insufficiency in advanced cancer patients. Cancer Treat. Rep. 1986; 70(12): 1383–7.
Walsh, D., and Nelson, K.A. Autonomic nervous system dysfunction in advanced cancer. Support. Care Cancer 2002; 10(7): 523–8.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
Ng, A.V., Alt, C.A., Gore, E.M. (2007). Fatigue. In: Feuerstein, M. (eds) Handbook of Cancer Survivorship. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-34562-8_8
Download citation
DOI: https://doi.org/10.1007/978-0-387-34562-8_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-34561-1
Online ISBN: 978-0-387-34562-8
eBook Packages: MedicineMedicine (R0)